Primary Sjögren's syndrome: the challenge for classification of disease manifestations
- PMID: 8656139
- DOI: 10.1046/j.1365-2796.1996.482818000.x
Primary Sjögren's syndrome: the challenge for classification of disease manifestations
Abstract
A new model for classifying the clinical disease manifestations of primary Sjögren's syndrome is introduced. Three "exocrine' and four "nonexocrine' subgroups of disease manifestations are defined. Accordingly, "surface exocrine disease' includes the diagnostic features from eyes, mouth, and the manifestations from the upper airways, skin and genital tract. Involvement of the excretory parenchyma of the lungs, hepatobiliary system, pancreas, gastrointestinal tract and kidneys is designated "internal organ exocrine disease'. We suggest "monoclonal B lymphocyte disease' to be an exocrine disease manifestation because it originates mostly from the immunoinflammatory foci of the autoimmune exocrinopathy. The nonexocrine manifestations are subgrouped into "inflammatory vascular disease'. "noninflammatory vascular disease', "mediator-induced disease' and "autoimmune endocrine disease'.
Comment on
-
A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study.J Intern Med. 1996 Jun;239(6):475-82. doi: 10.1046/j.1365-2796.1996.418817000.x. J Intern Med. 1996. PMID: 8656140
Similar articles
-
Classification of disease manifestations in primary Sjögren's syndrome: present status and a new proposal.Clin Rheumatol. 1995 Jul;14 Suppl 1:3-7. doi: 10.1007/BF03342630. Clin Rheumatol. 1995. PMID: 7493452 Review.
-
A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study.J Intern Med. 1996 Jun;239(6):475-82. doi: 10.1046/j.1365-2796.1996.418817000.x. J Intern Med. 1996. PMID: 8656140
-
Sjögren's syndrome: terminology.Clin Exp Rheumatol. 1995 Nov-Dec;13(6):693-6. Clin Exp Rheumatol. 1995. PMID: 8835240
-
Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.Best Pract Res Clin Rheumatol. 2007 Dec;21(6):989-1010. doi: 10.1016/j.berh.2007.09.001. Best Pract Res Clin Rheumatol. 2007. PMID: 18068857 Review.
-
Primary Sjögren's syndrome--clinical and laboratory markers of disease activity.Semin Arthritis Rheum. 1992 Oct;22(2):114-26. doi: 10.1016/0049-0172(92)90005-x. Semin Arthritis Rheum. 1992. PMID: 1439843 Review.
Cited by
-
Effect of inflammation on lacrimal gland function.Exp Eye Res. 2006 May;82(5):885-98. doi: 10.1016/j.exer.2005.10.018. Epub 2005 Nov 23. Exp Eye Res. 2006. PMID: 16309672 Free PMC article. Review.
-
Classification of disease manifestations in primary Sjögren's syndrome: present status and a new proposal.Clin Rheumatol. 1995 Jul;14 Suppl 1:3-7. doi: 10.1007/BF03342630. Clin Rheumatol. 1995. PMID: 7493452 Review.
-
Confocal Microscopy Abnormalities Preceding Antibody Positivity and Manifestations of Sjogren's Syndrome.Ocul Immunol Inflamm. 2023 Nov;31(9):1741-1745. doi: 10.1080/09273948.2022.2103713. Epub 2022 Aug 1. Ocul Immunol Inflamm. 2023. PMID: 35914299 Free PMC article.
-
Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome.Drugs. 1998 Sep;56(3):345-53. doi: 10.2165/00003495-199856030-00004. Drugs. 1998. PMID: 9777311 Review.
-
Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.Clin Rev Allergy Immunol. 2017 Dec;53(3):357-370. doi: 10.1007/s12016-017-8639-y. Clin Rev Allergy Immunol. 2017. PMID: 28871434 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical